Tag: IIL

Innate Immunotherapeutics ASX IIL Amplia Therapeutics biotech acquisition

Innate Immunotherapeutics shifts market focus via proposed biotech acquisition

Innate Immunotherapeutics (ASX: IIL) is proposing to absorb Amplia Therapeutics, a privately-owned Melbourne-based biopharmaceutical company, via an all-share deal to acquire the company including its...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS